[go: up one dir, main page]

ES494746A0 - Un procedimiento para la propagacion del virus de la hepati-tis a humana - Google Patents

Un procedimiento para la propagacion del virus de la hepati-tis a humana

Info

Publication number
ES494746A0
ES494746A0 ES494746A ES494746A ES494746A0 ES 494746 A0 ES494746 A0 ES 494746A0 ES 494746 A ES494746 A ES 494746A ES 494746 A ES494746 A ES 494746A ES 494746 A0 ES494746 A0 ES 494746A0
Authority
ES
Spain
Prior art keywords
virus
hepati
spread
human
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES494746A
Other languages
English (en)
Other versions
ES8106552A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22102684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES494746(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8106552A1 publication Critical patent/ES8106552A1/es
Publication of ES494746A0 publication Critical patent/ES494746A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32432—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32461—Methods of inactivation or attenuation
    • C12N2770/32464—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES494746A 1979-09-04 1980-09-03 Un procedimiento para la propagacion del virus de la hepati-tis a humana Granted ES494746A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7164879A 1979-09-04 1979-09-04

Publications (2)

Publication Number Publication Date
ES8106552A1 ES8106552A1 (es) 1981-08-16
ES494746A0 true ES494746A0 (es) 1981-08-16

Family

ID=22102684

Family Applications (1)

Application Number Title Priority Date Filing Date
ES494746A Granted ES494746A0 (es) 1979-09-04 1980-09-03 Un procedimiento para la propagacion del virus de la hepati-tis a humana

Country Status (10)

Country Link
EP (1) EP0025745B1 (es)
JP (2) JPS5639779A (es)
AT (1) ATE8409T1 (es)
CA (1) CA1164799A (es)
DE (1) DE3068528D1 (es)
DK (1) DK372780A (es)
ES (1) ES494746A0 (es)
GR (1) GR69953B (es)
IE (1) IE50191B1 (es)
PT (1) PT71739B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
US4416986A (en) * 1981-01-16 1983-11-22 Merck & Co., Inc. Methods of producing HBsAg
DE3135599A1 (de) * 1981-09-09 1983-08-25 Flehmig Bertram An menschliche fibroblastenzellen adaptierte hepatitis-a-viren
US4532215A (en) * 1982-04-07 1985-07-30 The United States Of America As Represented By The Department Of Health And Human Services Isolation of hepatitis A virus strain HM-175
US4636469A (en) * 1982-04-07 1987-01-13 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Isolation of hepatitis A virus strain HM-175
US4614793A (en) * 1983-10-14 1986-09-30 Merck & Co., Inc. Hepatitis A--subunit antigen
US4783407A (en) * 1985-09-30 1988-11-08 Merck & Co., Inc. Growth of hepatitus A virus in vero cells
DE3633550A1 (de) * 1986-10-02 1988-04-14 Behringwerke Ag Vaccine gegen hepatitis a
JPH0751513B2 (ja) * 1988-04-28 1995-06-05 国立予防衛生研究所長 Ａ型肝炎ワクチン
US5549896A (en) * 1991-05-08 1996-08-27 Schweiz. Serum- & Impfinstitut Bern Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
ES2056780T3 (es) * 1991-05-08 1998-08-16 Schweiz Serum & Impfinst Cepa del virus de la hepatitis, procedimiento de separacion de estas cepas y vacunas contra la hepatitis a.
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
GB9111230D0 (en) * 1991-05-24 1991-07-17 Wellcome Found Virus production
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL97686C (es) * 1956-04-30
GB878704A (en) * 1958-03-17 1961-10-04 Allied Lab Inc Propagation of attenuated infectious canine hepatitis virus in trypsinized tissue cultures of pig kidney and the preparation of a vaccine therefrom
US3935066A (en) * 1969-07-03 1976-01-27 Burroughs Wellcome Co. Cell lines
GB1300391A (en) * 1969-08-22 1972-12-20 Nat Res Dev Cell lines and virus culture
US4029764A (en) 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen
FR2398504A1 (fr) * 1977-07-29 1979-02-23 Tours Inst Virologie Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro

Also Published As

Publication number Publication date
IE801818L (en) 1981-03-04
DK372780A (da) 1981-03-05
IE50191B1 (en) 1986-03-05
ATE8409T1 (de) 1984-07-15
ES8106552A1 (es) 1981-08-16
JP2751950B2 (ja) 1998-05-18
EP0025745B1 (en) 1984-07-11
GR69953B (es) 1982-07-22
PT71739B (en) 1982-01-26
JPS5639779A (en) 1981-04-15
JPH07250677A (ja) 1995-10-03
EP0025745A1 (en) 1981-03-25
JPH0560915B2 (es) 1993-09-03
DE3068528D1 (en) 1984-08-16
CA1164799A (en) 1984-04-03
PT71739A (en) 1980-09-01

Similar Documents

Publication Publication Date Title
ES494746A0 (es) Un procedimiento para la propagacion del virus de la hepati-tis a humana
IT1132101B (it) Procedimento per la produzione di etanolo in forte concentrazione impiegando microorganismi immobilizzati
ES504199A0 (es) Un metodo para aumentar el rendimiento de vha en un cultivo celular in vitro
DK145613C (da) Apparat til dyrkning af vaevskulturceller
FI793195A (fi) Foerfarande foer framstaellning av ett aemne med bakteriostatisk aktivitet
SE8501534L (sv) Interferon epsilon
IT1099355B (it) Composizione adatta alla determinazione in cinetica del glucosio
PT86552A (de) Gama-glutamyl-transpeptidase deren herstellung und deren verwendung
ATE10806T1 (de) Verfahren zur herstellung von hepatitis boberfl[chenantigen.
IT1114284B (it) Procedimento per mantenere attiva la cultura di fermenti
IE781315L (en) Virus cultivation
ES496780A0 (es) Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.
SE8303925D0 (sv) Interferon e
ES8103161A1 (es) Metodo mejorado para la propagacion in vitro de parasitos debabesia
BG30774A3 (en) Method for obtaining of substituated withone base group in second and sixih position benzo- /1,2- d:4- d/ bistiazole
IT7850955A0 (it) Procedimento per la coltura aerobica di microorganismi
IT7948280A0 (it) Procedimento per il pretrattamento di microsupporti per colture cellulari
SU549106A1 (ru) Способ сохранени отдаленных гибридов
TUPYK et al. BIOCHEMICAL CHARACTERISTICS OF SPIRULINA PLATENSIS(GOM.) GEITL.: I. WATER-SOLUBLE GROUP B VITAMINS,(IN UKRANIAN)
FR1221020A (fr) Dispositif d'examen de la réaction de l'oeil humain aux excitations lumineuses
IT1130943B (it) Coltura termofila anaeroba di produttore di alcool
JPS5417748A (en) Optical fiber tube
AR230062A1 (es) Procedimiento para obtener oxazolinoazetidinonas utiles en la preparacion de analogos de oxigeno de las penicilinas y las oxazolin-azetidinonas a i obtenidas
JPS5467087A (en) Cultivating of chlorella using sugar mollasses as carbon source
IT1147722B (it) Procedimento per la produzione di codeina da culture di cellule